Aurobindo Pharma (NSE:AUROPHARMA) Days Sales Outstanding : 58.22 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Aurobindo Pharma Days Sales Outstanding?

Aurobindo Pharma's average Accounts Receivable for the three months ended in Dec. 2023 was ₹46,396 Mil. Aurobindo Pharma's Revenue for the three months ended in Dec. 2023 was ₹72,712 Mil. Hence, Aurobindo Pharma's Days Sales Outstanding for the three months ended in Dec. 2023 was 58.22.

The historical rank and industry rank for Aurobindo Pharma's Days Sales Outstanding or its related term are showing as below:

NSE:AUROPHARMA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.28 Med: 64.36 Max: 109.7
Current: 56.28

During the past 13 years, Aurobindo Pharma's highest Days Sales Outstanding was 109.70. The lowest was 56.28. And the median was 64.36.

NSE:AUROPHARMA's Days Sales Outstanding is ranked better than
66.07% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.15 vs NSE:AUROPHARMA: 56.28

Aurobindo Pharma's Days Sales Outstanding increased from Dec. 2022 (52.23) to Dec. 2023 (58.22).

Aurobindo Pharma Days Sales Outstanding Historical Data

The historical data trend for Aurobindo Pharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurobindo Pharma Days Sales Outstanding Chart

Aurobindo Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

61.64

62.03

58.10

58.70

62.86

Aurobindo Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															52.23	63.89	60.02	59.21	58.22

Competitive Comparison of Aurobindo Pharma's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Aurobindo Pharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurobindo Pharma's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurobindo Pharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Aurobindo Pharma's Days Sales Outstanding falls into.

Aurobindo Pharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Aurobindo Pharma's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (40122.6	+	44663.8)	/	2 )	/	246171.3	*	365
=	42393.2					/	246171.3	*	365
=	62.86

Aurobindo Pharma's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (46395.8	+	0)	/	1 )	/	72712.3	*	365 / 4
=	46395.8					/	72712.3	*	365 / 4
=	58.22

Aurobindo Pharma (NSE:AUROPHARMA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Aurobindo Pharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Aurobindo Pharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurobindo Pharma (NSE:AUROPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (NSE:AUROPHARMA) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

524804:India

Address

Plot No. 1, Survey No. 83/1, Galaxy, Floors: 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500 032

Website

https://www.aurobindo.com

Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Aurobindo Pharma (NSE:AUROPHARMA) Headlines

No Headlines